Ltd TIM- Tbilisi Institute of Medicine

Tbilisi 0160

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Heart Failure, Iron-deficiency

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed